Related by context. Frequent words. (Click for all words.) 76 treat male hypogonadism 74 Completes Patient Enrollment 74 oncolytic virus therapies 73 Hemispherx flagship products 73 Receives Orphan Drug Designation 73 Initiates Phase II 72 Tibotec Pharmaceuticals Ltd. 72 overactive bladder AA# 72 Therapeutic Competitors Report 72 gets USFDA nod 71 Auxilium transmucosal film 71 FUSILEV ® 71 BiTE R 71 Kuvan R 71 Meets Primary Endpoint 70 Fortical R 70 topical non steroidal 70 FACTIVE R gemifloxacin 70 candidate ridaforolimus 70 liposomal formulation 70 Belimumab 70 counter brand ESOTERICA 70 MKC# MT 70 Emergent marketed 70 DNA methyltransferase inhibitors 70 oral proteasome inhibitor 70 FOLOTYN ® 70 Enrolls First 69 Copegus R 69 PDE4 inhibitor 69 Presents Positive 69 Commences Phase 69 fibrosis IPF 69 FDA Accepts 69 Single Dose 69 Crucell NV NYSE Euronext 69 Inc Therapeutic Competitors 69 inhaled formulation 69 Bone Augmentation Material 69 Release Tablets 69 2 methoxyestradiol 69 Locked Nucleic Acid LNA 69 sorafenib tablets 69 multi kinase inhibitor 68 LungAlert TM 68 NASDAQ CRXL 68 Panzem R 68 Tesetaxel 68 investigational pan BCR 68 topical anti infective 68 Advancing Drugs 68 PEGylated anti 68 includes iFinix RealTime 68 Aztreonam 68 Eraxis 68 Completes Enrollment 68 autologous cellular immunotherapy 68 catheter occlusion 68 Alinia 68 optical biosensors 68 mild vasodilator 68 anticancer compound 68 Degarelix 68 Announces FDA Clearance 68 BiovaxID TM 68 system vaporizes unformulated 68 phenylketonuria PKU developed 68 Inhalation Aerosol 68 Archexin 68 Vidaza R 68 Therapeutic Competitors 67 Immune Globulin Human 67 refractory chronic lymphocytic 67 Saforis 67 VALSTAR 67 MERREM 67 Agonist MABA program 67 Lipid Polymer Micelle LPM 67 BYETTA ® 67 MKC# 67 Onalta 67 signal detection CTSD 67 Prism Pharmaceuticals 67 treat nicotine addiction 67 Argatroban 67 BY JENNIFER BAKER 67 VIVITROL ® 67 Company Nasdaq PRGO 67 Agile Therapeutics 67 dextofisopam 67 Indomethacin 67 Methylnaltrexone 67 cromolyn sodium 67 Inhalation Solution 67 Application MAA 67 peripherally acting 67 Phase III Clinical Trial 67 Medarex logo 67 Nivestim 67 trastuzumab DM1 T DM1 67 nucleoside analog